Showing results (331-340 of 375) with videos related to
Sort By:
Pageof 38
The British Journal of Radiology|January 21, 2020
Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinomaJiaming Chen, Bingxi He, Di Dong, et al.International Journal of Clinical Oncology|November 27, 2021
Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in ChinaJunshen He, Donglin Li, Ping Shen, et al.Archives of Gynecology and Obstetrics|February 5, 2021
Uterine corpus invasion in cervical cancer: a multicenter retrospective case-control studyWeili Li, Fangjie He, Ping Liu, et al.Alimentary Pharmacology & Therapeutics|March 12, 2021
Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesisVictor Chedid, Justin Brandler, Kayla Arndt, et al.Ebiomedicine|August 10, 2019
Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre studyCaixia Sun, Xin Tian, Zhenyu Liu, et al.Cancer Medicine|June 28, 2022
The pathological risk score: A new deep learning-based signature for predicting survival in cervical cancerChi Chen, Yuye Cao, Weili Li, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 20, 2021
Clinical features and prognostic factors of cervical villoglandular adenocarcinomaJia-Hua Chen, Hui Duan, Xiao-Bo Yu, et al.Gynecologic and Obstetric Investigation|October 16, 2009
Construction and clinical significance of normal uterine arterial vascular network modelsChunlin Chen, Rui Huang, Ping Liu, et al.BMC Cancer|March 26, 2022
Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapyPing Liu, Mei Ji, Yanxiang Kong, et al.Journal of Crohn'S & Colitis|August 17, 2021
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised TrialSéverine Vermeire, Geert D'Haens, Filip Baert, et al.Pageof 38